Morocco Pharmaceuticals & Healthcare Q2 2019
The Moroccan pharmaceutical market is expected to experience relatively modest growth in the coming years. Thegovernment's commitment to improving healthcare via the expansion of health insurance coverage and the country's growing non-communicable disease burden will provide significant tailwinds for future medicine sales. We believe generic drug makers will be themain beneficiaries as the state adopts a pro-generic stance and continues to slash drug prices. In addition, the country's lowpurchasing power, small pensionable population and inadequate public health system will dampen the demand for high-valuechronic disease treatments limiting innovative pharmaceutical sales.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook